Dendritic polyethylene glycol-modified folate–nickel nanotubes as an efficient antitumor nano-metal medicine
Source abstract
Abstract
Abstract Metal-containing nanomaterials have attracted substantial research efforts due to their rich compositional and structural diversity as well as the broad possible applications. However, the most metal-containing nanomaterials are normally only used as new delivery vehicles in the field of biomedicine but do not possess biologically activity by itself. Herein, we modified dendritic polyethylene glycol on one folate-nickel nanotube to fabricate a new-type of metal-containing nanotube PEG-FA-Ni NTs. We found PEG-FA-Ni NTs have exhibited excellent in vitro and in vivo antitumor activity comparable to the positive drugs doxorubicin and cisplatin. Meanwhile, this study indicates that the PEG-FA-Ni NTs may achieve more optimal anti-tumor effects by damaging DNA, blocking cell cycle and ultimately inducing apoptosis. All the results showed that PEG-FA-Ni NTs could be a potent nanomedicine for the further development and application on cancer therapy.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7–3010.3322/caac.21442 ↗
2. Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303(5665):1818–182210.1126/science.1095833 ↗
3. Matea CT, Mocan T, Tabaran F, Pop T, Mosteanu O, Puia C, Iancu C, Mocan L (2017) Quantum dots in imaging, drug delivery and sensor applications. Int J Nanomed 12:5421–543110.2147/IJN.S138624 ↗
4. Sun T, Zhang YS, Pang B, Hyun DC, Yang M, Xia Y (2014) Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed 53(46):12320–1236410.1002/anie.201403036 ↗
5. Einfalt T, Witzigmann D, Edlinger C, Sieber S, Goers R, Najer A, Spulber M, Onaca-Fischer O, Huwyler J, Palivan CG (2018) Biomimetic artificial organelles with in vitro and in vivo activity triggered by reduction in microenvironment. Nat Commun 9(1):112710.1038/s41467-018-03560-x ↗
6. Li Y-F, Gao Y, Chai Z, Chen C (2014) Nanometallomics: an emerging field studying the biological effects of metal-related nanomaterials. Metallomics 6(2):220–23210.1039/c3mt00316g ↗
7. Yan Y, Zhang J, Ren L, Tang C (2016) Metal-containing and related polymers for biomedical applications. Chem Soc Rev 45(19):5232–526310.1039/C6CS00026F ↗
8. Zhang H, Jiang W, Liu R, Zhang J, Zhang D, Li Z, Luan Y (2017) Rational design of metal organic framework nanocarrier-based codelivery system of doxorubicin hydrochloride/verapamil hydrochloride for overcoming multidrug resistance with efficient targeted cancer therapy. ACS Appl Mater Interfaces 9(23):19687–1969710.1021/acsami.7b05142 ↗
9. Ma A, Chen H, Cui Y, Luo Z, Liang R, Wu Z, Chen Z, Yin T, Ni J, Zheng M, Cai L (2019) Metalloporphyrin complex-based nanosonosensitizers for deep-tissue tumor theranostics by noninvasive sonodynamic therapy. Small 15(5):180402810.1002/smll.201804028 ↗
10. Liang S, Deng X, Chang Y, Sun C, Shao S, Xie Z, Xiao X, Ma P, Zhang H, Cheng Z, Lin J (2019) Intelligent hollow Pt-CuS janus architecture for synergistic catalysis-enhanced sonodynamic and photothermal cancer therapy. Nano Lett 19(6):4134–414510.1021/acs.nanolett.9b01595 ↗
11. Meng J, Liang X, Chen X, Zhao Y (2012) Biological characterizations of [Gd@C82(OH)22]nnanoparticles as fullerene derivatives for cancer therapy. Integr Biol 5(1):43–4710.1039/c2ib20145c ↗
12. Yang D, Zhao Y, Guo H, Li Y, Tewary P, Xing G, Hou W, Oppenheim JJ, Zhang N (2010) [Gd@C82(OH)22]n nanoparticles induce dendritic cell maturation and activate Th1 immune responses. ACS Nano 4(2):1178–118610.1021/nn901478z ↗
13. Meng J, Xing J, Ma X, Cao W, Lu J, Wang Y, Gao X, Sun B, Liang X, Zhao Y (2013) Metallofullerol nanoparticles with low toxicity inhibit tumor growth by induction of G0/G1 arrest. Nanomedicine 8(2):203–21310.2217/nnm.12.95 ↗
14. Meng H, Xing G, Sun B, Zhao F, Lei H, Li W, Song Y, Chen Z, Yuan H, Wang X, Long J, Chen C, Liang X, Zhang N, Chai Z, Zhao Y (2010) Potent angiogenesis inhibition by the particulate form of fullerene derivatives. ACS Nano 4(5):2773–278310.1021/nn100448z ↗
15. Chen C, Xing G, Wang J, Zhao Y, Li B, Tang J, Jia G, Wang T, Sun J, Xing L, Yuan H, Gao Y, Meng H, Chen Z, Zhao F, Chai Z, Fang X (2005) Multihydroxylated [Gd@C82(OH)22]n nanoparticles: antineoplastic activity of high efficiency and low toxicity. Nano Lett 5(10):2050–205710.1021/nl051624b ↗
16. Raja DS, Bhuvanesh NSP, Natarajan K (2012) A novel water soluble ligand bridged cobalt(ii) coordination polymer of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (isonicotinic) hydrazone: evaluation of the DNA binding, protein interaction, radical scavenging and anticancer activity. Dalton Trans 41(15):4365–437710.1039/c2dt12274j ↗
17. Liu LX, Li BX, Wang QY, Dong ZP, Li HM, Jin QM, Hong H, Zhang J, Wang Y (2016) An integrative folate-based metal complex nanotube as a potent antitumor nanomedicine as well as an efficient tumor-targeted drug carrier. Bioconjug Chem 27(12):2863–287310.1021/acs.bioconjchem.6b00520 ↗
18. Wang Y, Zhang C, Li H, Zhu G, Bao S-S, Wei S, Zheng L-M, Ren M, Xu Z (2015) Synthesis, characterization and in vitro anticancer activity of the biomolecule-based coordination complex nanotubes. J Mater Chem B 3(2):296–30510.1039/C4TB01135J ↗
19. Lu Y, Low PS (2002) Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Del Rev 54(5):675–69310.1016/S0169-409X(02)00042-X ↗
20. Cheng W, Nie J, Xu L, Liang C, Peng Y, Liu G, Wang T, Mei L, Huang L, Zeng X (2017) pH-sensitive delivery vehicle based on folic acid-conjugated polydopamine-modified mesoporous silica nanoparticles for targeted cancer therapy. ACS Appl Mater Interfaces 9(22):18462–1847310.1021/acsami.7b02457 ↗
21. Wang H, Zheng L, Peng C, Shen M, Shi X, Zhang G (2013) Folic acid-modified dendrimer-entrapped gold nanoparticles as nanoprobes for targeted CT imaging of human lung adencarcinoma. Biomaterials 34(2):470–48010.1016/j.biomaterials.2012.09.054 ↗
22. Zhou H, Fan Z, Deng J, Lemons PK, Arhontoulis DC, Bowne WB, Cheng H (2016) Hyaluronidase embedded in nanocarrier PEG shell for enhanced tumor penetration and highly efficient antitumor efficacy. Nano Lett 16(5):3268–327710.1021/acs.nanolett.6b00820 ↗
23. Huang Y, Huang Y, He J, Wang H, Luo Y, Li Y, Liu J, Zhong L, Zhao Y (2019) PEGylated immunoliposome-loaded endoglin single-chain antibody enhances anti-tumor capacity of porcine α1,3GT gene. Biomaterials 217:11923110.1016/j.biomaterials.2019.119231 ↗
24. Zhou M, Huang H, Wang D, Lu H, Chen J, Chai Z, Yao SQ, Hu Y (2019) Light-triggered PEGylation/dePEGylation of the nanocarriers for enhanced tumor penetration. Nano Lett 19(6):3671–367510.1021/acs.nanolett.9b00737 ↗
25. Liu K, Dai L, Li C, Liu J, Wang L, Lei J (2016) Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol–dihydroartemisinin conjugate. Sci Rep 6(1):2946110.1038/srep29461 ↗
26. Gillich T, Acikgöz C, Isa L, Schlüter AD, Spencer ND, Textor M (2013) PEG-stabilized core-shell nanoparticles: impact of linear versus dendritic polymer shell architecture on colloidal properties and the reversibility of temperature-induced aggregation. ACS Nano 7(1):316–32910.1021/nn304045q ↗
27. Zhang S, Xiong P, Yang X, Wang X (2011) Novel PEG functionalized graphene nanosheets: enhancement of dispersibility and thermal stability. Nanoscale 3(5):2169–217410.1039/c0nr00923g ↗
28. Qian Y, Wei P, Jiang P, Li Z, Yan Y, Liu J (2013) Preparation of a novel PEG composite with halogen-free flame retardant supporting matrix for thermal energy storage application. Appl Energy 106:321–32710.1016/j.apenergy.2012.12.070 ↗
29. Zhang Y, Li Y, Yan X-P (2009) Photoactivated CdTe/CdSe quantum dots as a near infrared fluorescent probe for detecting biothiols in biological fluids. Anal Chem 81(12):5001–500710.1021/ac900394e ↗
30. Browning RJ, Reardon PJT, Parhizkar M, Pedley RB, Edirisinghe M, Knowles JC, Stride E (2017) Drug delivery strategies for platinum-based chemotherapy. ACS Nano 11(9):8560–857810.1021/acsnano.7b04092 ↗
31. Janzen DM, Tiourin E, Salehi JA, Paik DY, Lu J, Pellegrini M, Memarzadeh S (2015) RETRACTED ARTICLE: an apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer. Nat Commun 6(1):795610.1038/ncomms8956 ↗
32. Uz M, Bulmus V, Alsoy AS (2016) Effect of PEG grafting density and hydrodynamic volume on gold nanoparticle-cell interactions: an investigation on cell cycle, apoptosis, and dna damage. Langmuir 32(23):5997–600910.1021/acs.langmuir.6b01289 ↗
33. Saei AA, Yazdani M, Lohse SE, Bakhtiary Z, Serpooshan V, Ghavami M, Asadian M, Mashaghi S, Dreaden EC, Mashaghi A, Mahmoudi M (2017) Nanoparticle surface functionality dictates cellular and systemic toxicity. Chem Mater 29(16):6578–659510.1021/acs.chemmater.7b01979 ↗
34. Kaul G, Amiji M (2004) Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model. J Drug Target 12(9–10):585–59110.1080/10611860400013451 ↗
35. van Vlerken LE, Vyas TK, Amiji MM (2007) Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res 24(8):1405–141410.1007/s11095-007-9284-6 ↗